A Validated Model of Serum Anti-Müllerian Hormone from Conception to Menopause
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Anti-Müllerian hormone (AMH) is a product of growing ovarian follicles. The concentration of AMH in blood may also reflect the non-growing follicle (NGF) population, i.e. the ovarian reserve, and be of value in predicting reproductive lifespan. A full description of AMH production up to the menopause has not been previously reported. METHODOLOGY/PRINCIPAL FINDINGS: By searching the published literature for AMH concentrations in healthy pre-menopausal females, and using our own data (combined n = 3,260) we have generated and robustly validated the first model of AMH concentration from conception to menopause. This model shows that 34% of the variation in AMH is due to age alone. We have shown that AMH peaks at age 24.5 years, followed by a decline to the menopause. We have also shown that there is a neonatal peak and a potential pre-pubertal peak. Our model allows us to generate normative data at all ages. CONCLUSIONS/SIGNIFICANCE: These data highlight key inflection points in ovarian follicle dynamics. This first validated model of circulating AMH in healthy females describes a transition period in early adulthood, after which AMH reflects the progressive loss of the NGF pool. The existence of a neonatal increase in gonadal activity is confirmed for females. An improved understanding of the relationship between circulating AMH and age will lead to more accurate assessment of ovarian reserve for the individual woman.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
The Elements of Statistical Learning
Hastie, T., Friedman, J., & Tibshirani, R. (2001) · Springer Series in Statistics · doi:10.1007/978-0-387-21606-5 · Cited by 24,162
Initial and cyclic recruitment of ovarian follicles
McGee, E. A., & Hsueh, A. J. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0394 · Cited by 1,771 · cited 3×
“After puberty, at every new cycle a limited number of follicles are recruited from this cohort of small growing follicles (cyclic recruitment), followed by a final selection for dominance and ovulation of a single follicle [2,3].”
BackgroundRegulation of ovarian follicular development in primates: facts and hypotheses
GOUGEON, A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-121 · Cited by 1,497
Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause
Faddy, M. J., Gosden, R. G., Gougeon, A., Richardson, S. J., & Nelson, J. F. (1992) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137570 · Cited by 1,365
Weenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
Ovarian aging: mechanisms and clinical consequences
Broekmans, F. J., Soules, M. R., & Fauser, B. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0006 · Cited by 1,248 · cited 1×
“The human ovary establishes its complete complement of primordial follicles during fetal life, with recruitment and thereby depletion of this dormant primordial follicle pool required for normal fertility but ultimately leading to reproductive senescence [1].”
BackgroundControl of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1
Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (1999) · Endocrinology · doi:10.1210/endo.140.12.7204 · Cited by 1,011
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
Cited by
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
The physiology and clinical utility of anti-Müllerian hormone in women
Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., Griesinger, G., Kelsey, T. W., La Marca, A., Lambalk, C., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt062 · Cited by 1,049
Self-citationAnti-Müllerian hormone: ovarian reserve testing and its potential clinical implications
Broer, S. L., Broekmans, F. J. M., Laven, J. S. E., & Fauser, B. C. J. M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu020 · Cited by 683
The Menopause Transition: Signs, Symptoms, and Management Options
Santoro, N., Roeca, C., Peters, B. A., & Neal-Perry, G. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa764 · Cited by 631
Anti-müllerian hormone and ovarian reserve: Update on assessing ovarian function
Moolhuijsen, L. M. E., & Visser, J. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa513 · Cited by 584
“From age 25 years onward, AMH levels start to decline to undetectable levels at menopause, and only from this age onward, a negative correlation between AMH levels and age can be observed (11, 12).”
BackgroundQiao, J., Wang, Y., Li, X., Jiang, F., Zhang, Y., Ma, J., Song, Y., Ma, J., Fu, W., Pang, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32708-2 · Cited by 569
Dewailly, D., Robin, G., Peigne, M., Decanter, C., Pigny, P., & Catteau-Jonard, S. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw027 · Cited by 526
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
How do chemotherapeutic agents damage the ovary?
Morgan, S., Anderson, R. A., Gourley, C., Wallace, W. H., & Spears, N. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms022 · Cited by 409
Self-citationMitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations
Kang, E., Wu, J., Gutierrez, N. M., Koski, A., Tippner-Hedges, R., Agaronyan, K., Platero-Luengo, A., Martinez-Redondo, P., Ma, H., Lee, Y., et al. (2016) · Nature · doi:10.1038/nature20592 · Cited by 326
Anderson, R. A., Mitchell, R. T., Kelsey, T. W., Spears, N., Telfer, E. E., & Wallace, W. H. B. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00039-x · Cited by 293
Self-citationIliodromiti, S., Kelsey, T. W., Anderson, R. A., & Nelson, S. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1393 · Cited by 280
Self-citationAnti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency
Visser, J. A., Schipper, I., Laven, J. S. E., & Themmen, A. P. N. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.224 · Cited by 264
Iliodromiti, S., Anderson, R. A., & Nelson, S. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu062 · Cited by 260
Self-citationSerum Anti-Müllerian Hormone Levels in Healthy Females: A Nomogram Ranging from Infancy to Adulthood
Lie Fong, S., Visser, J. A., Welt, C. K., de Rijke, Y. B., Eijkemans, M. J. C., Broekmans, F. J., Roes, E. M., Peters, W. H. M., Hokken-Koelega, A. C. S., Fauser, B. C. J. M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1440 · Cited by 259
Biomarkers of ovarian response: current and future applications
Nelson, S. M. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.11.051 · Cited by 220
Self-citationAnderson, R. A., McLaughlin, M., Wallace, W. H. B., Albertini, D. F., & Telfer, E. E. (2014) · Human Reproduction · doi:10.1093/humrep/det388 · Cited by 176
“How this changes over childhood and through puberty is unknown, and there are no previous data on the in vitro growth potential of follicles from pre-pubertal and pubertal girls. study design, size, duration: Ovarian biopsies from five pre-pubertal and seven pubertal girls and 19 adult women were…”
BackgroundSelf-citationRosenfield, R. L., Wroblewski, K., Padmanabhan, V., Littlejohn, E., Mortensen, M., & Ehrmann, D. A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.059 · Cited by 80
Anti-Müllerian hormone in obese adolescent girls with polycystic ovary syndrome
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., Lee, S., Nasr, A., & Arslanian, S. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.10.015 · Cited by 54
“This direct relationship between age and AMH in adolescent girls is opposite to that in adult women with and without PCOS [12e14], but in agreement with the known age-specific changes in AMH levels from conception to menopause [39], irrespective of the presence or absence of PCOS.”
Reproductive Complications in Childhood Cancer Survivors
van Santen, H. M., van de Wetering, M. D., Bos, A. M. E., vd Heuvel-Eibrink, M. M., van der Pal, H. J., & Wallace, W. H. (2020) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2020.08.003 · Cited by 42
Self-citationClément, F., Crépieux, P., Yvinec, R., & Monniaux, D. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110877 · Cited by 16
Metadata
- Authors
- Kelsey, T. W., Wright, P., Nelson, S. M., Anderson, R. A., & Wallace, W. H. B.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-07-15
- Volume
- 6
- Issue
- 7
- Pages
- e22024
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2005527513
- Cited by
- 457
- References
- 52
- FWCI
- 32.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.